132 related articles for article (PubMed ID: 2522598)
1. A comparison of the effects of the selective 5-HT uptake inhibitor WY 27587 on 5-HT uptake into platelets and synaptosomes in the rat.
Billingsley AJ; Brammer NT; Wood MD; Minchin MC
Neuropharmacology; 1989 Jan; 28(1):33-6. PubMed ID: 2522598
[TBL] [Abstract][Full Text] [Related]
2. Panuramine, a selective inhibitor of uptake of 5-hydroxytryptamine in the brain of the rat.
Blurton PA; Broadhurst AM; Cross JA; Ennis C; Wood MD; Wyllie MG
Neuropharmacology; 1984 Sep; 23(9):1049-52. PubMed ID: 6514142
[TBL] [Abstract][Full Text] [Related]
3. Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor.
Thomas DR; Nelson DR; Johnson AM
Psychopharmacology (Berl); 1987; 93(2):193-200. PubMed ID: 2962217
[TBL] [Abstract][Full Text] [Related]
4. Effect of a specific 5-HT uptake inhibitor, citalopram (Lu 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro.
Hyttel J
Psychopharmacology (Berl); 1978 Dec; 60(1):13-8. PubMed ID: 104340
[TBL] [Abstract][Full Text] [Related]
5. Effects of 4-(3-indolyl-alkyl)piperidine derivatives on uptake and release of noradrenaline, dopamine and 5-hydroxytryptamine in rat brain synaptosomes, rat heart and human blood platelets.
Le Fur G; Uzan A
Biochem Pharmacol; 1977 Mar; 26(6):497-503. PubMed ID: 849346
[No Abstract] [Full Text] [Related]
6. Ifoxetine, a compound with atypical effects on serotonin uptake.
Waldmeier PC; Maître L; Baumann PA; Hauser K; Bischoff S; Bittiger H; Paioni R
Eur J Pharmacol; 1986 Oct; 130(1-2):1-10. PubMed ID: 2877890
[TBL] [Abstract][Full Text] [Related]
7. Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171.
Hyttel J
Psychopharmacology (Berl); 1977 Mar; 51(3):225-33. PubMed ID: 403537
[TBL] [Abstract][Full Text] [Related]
8. 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents.
Hekmatpanah CR; Peroutka SJ
Eur J Pharmacol; 1990 Feb; 177(1-2):95-8. PubMed ID: 1971219
[TBL] [Abstract][Full Text] [Related]
9. CGP 6085 A, a new, specific, inhibitor of serotonin uptake: neurochemical characterization and comparison with other serotonin uptake blockers.
Waldmeier PC; Baumann PA; Maítre L
J Pharmacol Exp Ther; 1979 Oct; 211(1):42-9. PubMed ID: 490325
[No Abstract] [Full Text] [Related]
10. Effect of flunarizine and calcium on serotonin uptake in human and rat blood platelets and rat synaptosomes.
Jensen PN; Smith DF; Poulsen JH; Møller HJ; Rosenberg R
Biol Psychiatry; 1994 Jul; 36(2):118-23. PubMed ID: 7948444
[TBL] [Abstract][Full Text] [Related]
11. Du 24565, a quipazine derivative, a potent selective serotonin uptake inhibitor.
Vaatstra WJ; Deiman-Van Aalst WM; Eigeman L
Eur J Pharmacol; 1981 Mar; 70(2):195-202. PubMed ID: 6973481
[TBL] [Abstract][Full Text] [Related]
12. A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine.
Wong DT; Bymaster FP; Horng JS; Molloy BB
J Pharmacol Exp Ther; 1975 Jun; 193(3):804-11. PubMed ID: 1151730
[TBL] [Abstract][Full Text] [Related]
13. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin, dopamine and noradrenaline uptake in rat brain synaptosomes.
Komulainen H; Tuomisto J; Airaksinen MM; Kari I; Peura P; Pollari L
Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):299-307. PubMed ID: 7368949
[TBL] [Abstract][Full Text] [Related]
14. Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression.
Aberg-Wistedt A; Jostell KG; Ross SB; Westerlund D
Psychopharmacology (Berl); 1981; 74(4):297-305. PubMed ID: 6457309
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity.
Yáñez M; Fraiz N; Cano E; Orallo F
Biochem Biophys Res Commun; 2006 Jun; 344(2):688-95. PubMed ID: 16631124
[TBL] [Abstract][Full Text] [Related]
16. Uptake of serotonin into rat platelets and synaptosomes: comparative structure-activity relationships, energetics and evaluation of the effects of acute and chronic nortriptyline administration.
Slotkin TA; Whitmore WL; Dew KL; Kilts CD
Brain Res Bull; 1986 Jul; 17(1):67-73. PubMed ID: 3756546
[TBL] [Abstract][Full Text] [Related]
17. The modulation of [3H]noradrenaline and [3H]serotonin release from rat brain synaptosomes is not mediated by the alpha 2B-adrenoceptor subtype.
Gobbi M; Frittoli E; Mennini T
Naunyn Schmiedebergs Arch Pharmacol; 1990 Oct; 342(4):382-6. PubMed ID: 1979424
[TBL] [Abstract][Full Text] [Related]
18. Metaraminol uptake by human thrombocytes: a poor model for neuronal noradrenaline uptake.
Waldmeier PC; Baumann PA
Experientia; 1977 Oct; 33(10):1354-5. PubMed ID: 908413
[TBL] [Abstract][Full Text] [Related]
19. Assessment of blood platelets as a model for CNS response: comparative effects of caffeine on 5-HT uptake and release mechanisms in rat platelets and rat brain serotonin neurons.
Chou DT; Cuzzone H; Hirsh KR
Life Sci; 1983 Sep; 33(12):1149-56. PubMed ID: 6888169
[TBL] [Abstract][Full Text] [Related]
20. Serotonin uptake and imipramine binding in blood platelets and brain of Fawn-hooded and Sprague Dawley rats.
Arora RC; Tong C; Jackman HL; Stoff D; Meltzer HY
Life Sci; 1983 Aug; 33(5):437-42. PubMed ID: 6877030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
